ArticleEcancermedicalscience2019
Successful osimertinib rechallenge following drug-induced pneumonitis after previous anti-PDL1 exposure.
Guilherme Harada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2019
this papercites it